4D Molecular Therapeutics (FDMT) Receivables - Other (2019 - 2022)
Historic Receivables - Other for 4D Molecular Therapeutics (FDMT) over the last 3 years, with Q4 2022 value amounting to $700000.0.
- 4D Molecular Therapeutics' Receivables - Other changed 0.0% to $700000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $700000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $700000.0 for FY2022, which is 0.0% changed from last year.
- As of Q4 2022, 4D Molecular Therapeutics' Receivables - Other stood at $700000.0, which was down 0.0% from $700000.0 recorded in Q4 2021.
- In the past 5 years, 4D Molecular Therapeutics' Receivables - Other registered a high of $700000.0 during Q4 2021, and its lowest value of $149000.0 during Q4 2019.
- In the last 3 years, 4D Molecular Therapeutics' Receivables - Other had a median value of $630500.0 in 2021 and averaged $527500.0.
- Examining YoY changes over the last 5 years, 4D Molecular Therapeutics' Receivables - Other showed a top increase of 0.0% in 2022 and a maximum decrease of 0.0% in 2022.
- Quarter analysis of 3 years shows 4D Molecular Therapeutics' Receivables - Other stood at $149000.0 in 2019, then skyrocketed by 369.8% to $700000.0 in 2021, then changed by 0.0% to $700000.0 in 2022.
- Its Receivables - Other was $700000.0 in Q4 2022, compared to $700000.0 in Q4 2021 and $561000.0 in Q1 2021.